Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer (Q28241808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

20 March 2020

corrigendum / erratum

0 references

author

Roberto Piñeiro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ee Lyn Lim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Cheryl Scudamore

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Martin Turner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Klaus Okkenhaug

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

14

Bart Vanhaesebroeck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Khaled Ali

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Dalya R Soond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Thorsten Hagemann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Wayne Pearce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hicham Bouabe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Timothy Hancox

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Heather Maecker

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Lori Friedman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

11 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

407-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

7505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Signaling by the phosphoinositide 3-kinase family in immune cells

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Potent and highly selective benzimidazole inhibitors of PI3-kinase delta

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Coordinated regulation of myeloid cells by tumours

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

p110δ, a novel phosphoinositide 3-kinase in leukocytes

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

The PI3K p110δ regulates expression of CD38 on regulatory T cells

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

PI3K and cancer: lessons, challenges and opportunities

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

24 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Paths to stemness: building the ultimate antitumour T cell.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

PI3Kδ is essential for tumor clearance mediated by cytotoxic T lymphocytes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Adoptive immunotherapy of cancer using CD4(+) T cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Regulatory T cells and treatment of cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4501086

Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24919154

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24919154

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NATURE13444

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 March 2020

1027340229

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24919154%20AND%20SRC:MED&resulttype=core&format=json